Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 2, Issue 8, Pages 919-928Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/14712598.2.8.919
Keywords
cancer; dendritic cells; vaccine
Funding
- NCI NIH HHS [CA 63350, CA 73743] Funding Source: Medline
Ask authors/readers for more resources
Dendritic cells (DCs) are the most potent professional antigen-presenting cells (APCs), and are, capable of stimulating naive T cells and driving primary immune responses. Due to this unique property, DCs represent both vectors and targets for immunological intervention in numerous diseases and are optimal candidates for vaccination protocols in cancer. This review provides an overview of DC immunobiology and the integration of these important APCs in immunotherapies for cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available